Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: J Hepatol. 2010 Sep 22;54(4):753–759. doi: 10.1016/j.jhep.2010.07.040

Table 2.

Characteristics of patients with NAFLD according to Early (Stages 0-2) versus Advanced (Stages 3-4) liver fibrosis*

Stages 0-2 (n=742) Stages 3-4 (n=338) p-value
Female Gender 445 (60.0%) 238 (70.4%) 0.001
Age (years) 46.7 ± 11.9 54.0 ± 10.4 <0.0001
Race / Ethnicity 0.007
    White 556 (75.1 %) 273 (80.8%)
    Hispanic 99 (13.4%) 22 (6.5%)
    Black 20 (2.7%) 8 (2.4%)
    Other 65 (8.8%) 35 (10.4%)
Hispanic, yes vs. no 99 (13.3%) 22 (6.5%) 0.0008
BMI, kg/m2 34.0 ± 6.3 34.9 ± 6.5 0.03
    BMI >=30 kg/ m2 515 (69.9%) 253 (74.9%) 0.10
Diabetes Mellitus Type 2 164 (22.1%) 154 (45.6%) <0.0001
History of Regular Smoking, yes vs. no 194 (26.3%) 114 (33.8%) 0.01
    Current smoker, yes vs. no 67 (9.1%) 34 (10.1%) 0.65
    History of >=10 vs. <10 pack-years 147 (20.0%) 109 (32.3%) <0.0001
    Pack-years, median (IQR) 0 (0.0, 6.0) 0 (0.0, 16.5) 0.0002
Alcohol use, not abstinent vs. lifetime abstinent 389 (52.4%) 147 (43.5%) 0.007
Household income <15,000 vs. >=15,000/year 62 (8.5%) 30 (9.0%) 0.81
Biopsy length, mm 18.2± 9.5 19.9 ± 10.6 0.01
*

Expressed as percent for categorical variables and mean (±SD) for continuous variables. Median (IQR) is shown for pack-years variable because of its non-normal distribution.